Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

A bad choice of hard to prove endpoints. No Stelar results/data recorded during the crazy scrambles at the foreign hospitals. Everyone was getting 'Remdeathisnear' to confound some data results. *
AGN should Never had a 40 mg arm.!.
Investors and CSO/CEO were aiming for a home run when baserunners were what was needed then. A simple treatment, Not "the Cure" BS...IMO...
Some good data still and the IL-6 stuff too.

"Feedback from the FDA" and a pass at the DSMB, but they never applied for the Phase 3. Fair point.

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/53/algernon-pharmaceuticals-receives-green-light-from-dsmb-to

Continued supporting data from the CC/IPF study for the use of Ifenprodil in chronic lung diseases seems probable.

IMO, do the $2M to keep rolling. ASAP. Prepare the next stepss ..GLTA...

*{Gilead (Wuhan V.I.-Bat Soup) Rem} bought up All the hospital beds to use for Rem CTs that eventually also showed no real results...IMO...

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/35/algernon-pharmaceuticals-announces-topline-data-from-its

<>

The Company’s decision was based on several factors including the overall findings of the Phase 2b COVID-19 study final data set, the global rate of vaccinations to date, other COVID-19 drug treatment programs under development, and the projected trial size, costs and timelines needed to successfully complete a Phase 3 trial. Feedback recently received from the U.S. Food and Drug Administration regarding the Company’s end of Phase 2 meeting request was also informative.

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/25/algernon-pharmaceuticals-announces-it-will-not-advance